110 related articles for article (PubMed ID: 7536812)
1. Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats.
Maragos WF; Silverstein FS
J Neurochem; 1995 May; 64(5):2362-5. PubMed ID: 7536812
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase.
Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
Neuropharmacology; 1996 Apr; 35(4):459-65. PubMed ID: 8793908
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.
Buisson A; Margaill I; Callebert J; Plotkine M; Boulu RG
J Neurochem; 1993 Aug; 61(2):690-6. PubMed ID: 7687658
[TBL] [Abstract][Full Text] [Related]
4. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis.
Connop BP; Boegman RJ; Jhamandas K; Beninger RJ
Brain Res; 1995 Apr; 676(1):124-32. PubMed ID: 7540931
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.
Greene JG; Greenamyre JT
J Neurochem; 1995 Jan; 64(1):430-6. PubMed ID: 7528265
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
7. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
[TBL] [Abstract][Full Text] [Related]
8. Malonate produces striatal lesions by indirect NMDA receptor activation.
Henshaw R; Jenkins BG; Schulz JB; Ferrante RJ; Kowall NW; Rosen BR; Beal MF
Brain Res; 1994 May; 647(1):161-6. PubMed ID: 8069700
[TBL] [Abstract][Full Text] [Related]
9. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo.
Schulz JB; Matthews RT; Jenkins BG; Ferrante RJ; Siwek D; Henshaw DR; Cipolloni PB; Mecocci P; Kowall NW; Rosen BR
J Neurosci; 1995 Dec; 15(12):8419-29. PubMed ID: 8613773
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
Beal MF; Brouillet E; Jenkins B; Henshaw R; Rosen B; Hyman BT
J Neurochem; 1993 Sep; 61(3):1147-50. PubMed ID: 7689641
[TBL] [Abstract][Full Text] [Related]
11. Malonate-induced degeneration of basal forebrain cholinergic neurons: attenuation by lamotrigine, MK-801, and 7-nitroindazole.
Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
J Neurochem; 1997 Mar; 68(3):1191-9. PubMed ID: 9048766
[TBL] [Abstract][Full Text] [Related]
12. Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors.
Ohta K; Shimazu K; Komatsumoto S; Araki N; Shibata M; Fukuuchi Y
Neuroreport; 1994 Mar; 5(7):766-8. PubMed ID: 7517194
[TBL] [Abstract][Full Text] [Related]
13. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity.
Matthews RT; Yang L; Beal MF
Exp Neurol; 1997 Feb; 143(2):282-6. PubMed ID: 9056390
[TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.
Maragos WF; Jakel RJ; Pang Z; Geddes JW
Exp Neurol; 1998 Dec; 154(2):637-44. PubMed ID: 9878198
[TBL] [Abstract][Full Text] [Related]
15. A dual role for nitric oxide in NMDA-mediated toxicity in vivo.
Globus MY; Prado R; Sanchez-Ramos J; Zhao W; Dietrich WD; Busto R; Ginsberg MD
J Cereb Blood Flow Metab; 1995 Nov; 15(6):904-13. PubMed ID: 7593350
[TBL] [Abstract][Full Text] [Related]
16. Reduction of striatal N-methyl-D-aspartate toxicity by inhibition of nitric oxide synthase.
Kollegger H; McBean GJ; Tipton KF
Biochem Pharmacol; 1993 Jan; 45(1):260-4. PubMed ID: 7678741
[TBL] [Abstract][Full Text] [Related]
17. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2002 Jul; 176(1):193-202. PubMed ID: 12093096
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid.
Galasso JM; Bazzett TJ; Becker JB; Albin RL
Neuroreport; 1995 Jul; 6(11):1505-8. PubMed ID: 7579135
[TBL] [Abstract][Full Text] [Related]
19. Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.
Maragos WF; Young KL; Altman CS; Pocernich CB; Drake J; Butterfield DA; Seif I; Holschneider DP; Chen K; Shih JC
Neurochem Res; 2004 Apr; 29(4):741-6. PubMed ID: 15098936
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum.
Bazzett TJ; Falik RC; Becker JB; Albin RL
Brain Res; 1996 Apr; 718(1-2):228-32. PubMed ID: 8773793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
